Next Earnings date is expected on
02/13/2023
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Hempacco (HPCO) shares surged 63% premarket Wednesday after the company reported revenue of about $2.8 million for the six months ended June 30, a 486%...
Cel-Sci (CVM) reported Monday positive data from a phase 3 study of its Neoadjuvant Multikine injection in terms of tumor response and overall survival in...
Cel-Sci (CVM) said Friday that positive findings from its phase 3 trial of Multikine in head and neck cancer have been published on clinicaltrials.gov per...
| Address | 8229 Boone Boulevard Vienna, Virginia 22182 |
| Phone | +1.703.506.9460 |
| Number of Employees | N/A |
| Recent SEC Filing | 02/08/2023 SC 13G/A |
| CEO, Chief Financial Officer, Treasurer & Director | Geert R. Kersten |
| Secretary & Senior Vice President-Operations | Patricia B. Prichep |
| Chief Scientific Officer | Eyal Talor |
| Vice President-Quality Assurance | William Jones |
| Price Open | $2.76 |
| Previous Close | $2.78 |
| 52 Week Range | $1.88 - 6.51 |
| Market Capitalization | $121.0 M |
| Shares Outstanding | 43.7 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 02/13/2023 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.88 |
| Beta vs. S&P 500 | N/A |
| Revenue | $476.6 K |
| Net Profit Margin | N/A |
| Return on Equity | -87.71% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
